| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 79.54M | 105.31M | 77.09M | 158.86M | 154.10M |
| Gross Profit | -23.67M | -22.53M | -14.43M | -7.63M | -25.38M |
| EBITDA | -83.42M | -81.60M | -78.95M | -93.01M | -148.57M |
| Net Income | -120.10M | -132.38M | -184.41M | -260.67M | -173.12M |
Balance Sheet | |||||
| Total Assets | 81.56M | 126.94M | 173.86M | 398.28M | 809.19M |
| Cash, Cash Equivalents and Short-Term Investments | 4.58M | 27.93M | 13.68M | 119.10M | 195.09M |
| Total Debt | 363.63M | 356.08M | 344.29M | 365.65M | 391.13M |
| Total Liabilities | 848.08M | 817.64M | 694.09M | 733.56M | 787.34M |
| Stockholders Equity | -429.96M | -390.16M | -250.62M | -128.80M | 126.27M |
Cash Flow | |||||
| Free Cash Flow | -85.37M | -28.89M | -4.64M | -16.41M | -53.53M |
| Operating Cash Flow | -85.31M | -28.03M | -4.64M | -2.40M | -35.78M |
| Investing Cash Flow | 10.53M | -5.13M | -13.58M | -16.16M | -30.75M |
| Financing Cash Flow | 62.85M | 46.83M | -7.79M | 3.69M | 86.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$837.50M | 4.72 | 19.46% | 8.89% | -8.00% | -11.37% | |
63 Neutral | HK$2.40B | 6.20 | 25.55% | 1.12% | 22.22% | 196.73% | |
63 Neutral | HK$2.32B | 1.52 | 15.14% | 12.14% | -0.95% | 2.58% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
49 Neutral | HK$882.54M | 29.60 | 2.26% | 1.28% | -14.05% | 20.05% | |
45 Neutral | HK$195.18M | -1.07 | -31.61% | ― | -39.86% | -377.55% | |
40 Underperform | HK$133.73M | -0.63 | ― | ― | -25.00% | 23.32% |